Participate

Click on any of the studies below to learn more about whether you might be eligible to participate and contact our research team.


Effects of cannabidiol in alcohol use disorder

A Phase I/II Randomized, Double-Blind, Placebo-Controlled Trial of Cannabidiol for Alcohol Use Disorder

The purpose of this research study is to see how safe and effective cannabidiol (CBD) is for the treatment of alcohol dependence. We also would like to assess its effects on thinking, behavior and habits of people with Alcohol Use disorder.

A Study of Psilocybin for Major Depressive Disorder (MDD)

A Multi-Center Randomized Double-Blind Support-of-Concept Phase 2 Study of Single-Dose Psilocybin for Major Depressive Disorder (MDD)

The purpose of this research is to study the medical and safety effects of a single dose of an investigational drug called psilocybin compared to an active placebo in participants with Major Depressive Disorder (MDD) who are otherwise medically healthy.

MDMA study is for the treatment of post-traumatic stress disorder (PTSD)

The purpose of this research study is to see how safe and effective Methylenedioxymethamphetamine (MDMA) is for the treatment of post-traumatic stress disorder (PTSD). MDMA is currently an experimental medication and has not been approved as a safe or effective treatment for any health condition. This study, sponsored by the Multidisciplinary Association for Psychedelic Studies, is a Phase 3 study intended to provide evidence of safety and efficacy that will be submitted to the United States Food and Drug Administration (FDA) as part of an application to permit the use of MDMA as a treatment for PTSD. Participants in the study receive MDMA or placebo in three experimental sessions, together with a total of 12 non-drug psychotherapy sessions. MDMA causes release of serotonin and other neurotransmitters in the brain, which is thought to alter the way people think and feel about traumatic experiences they have had.